Arylesterase activity is associated with antioxidant intake and Paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet

EXCLI Journal

Volumn 13, Issue , 2014, Pages 416-426

  de la Iglesia, Rocio ^a   Mansego, Maria L ^a,b   Sánchez Muniz, Francisco J ^c   Angeles Zulet, M ^a,b   Alfredo Martinez, J ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antioxidants; ARE; DNA methylation; Energy restriction; Metabolic syndrome; Obesity; PON1 gene

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; ASCORBIC ACID; DNA; LYCOPENE; TOCOPHEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; DNA METHYLATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FAT MASS; FEMALE; GENE; HUMAN; MALE; METABOLIC SYNDROME X; PON1 GENE; PROMOTER REGION; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION STUDY;

EID: 84899130698     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Akis N, Pala K, Meric-Utku A, Seyithan B, Sarandol E, Aytekin H. Hypertension in children (12-14 years)-a case-control study in Bursa, Turkey. Turk J Pediatr 2009;51:437-43.
2. Aksoy H, Aksoy AN, Ozkan A, Polat H. Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum. J Clin Lab Anal 2009; 23:105-9.
3. ALCE IGENIERIA DIAL Programme (2011). Evaluation and design diets programme. http://www.alceingenieria.net/nutricion.htm.
4. Bartels M, Meyer zu Vilsendorf A, Kassahun WT, von Gerstenbergk B, Engelhart K, Meyer zu Vilsendorf E et al. Protective effect of antioxidative vitamins against lipid peroxidation in liver ischemia and reperfusion-an animal experimental study. EXCLI Journal 2007;6:152-66.
5. Canales A, Sanchez-Muniz FJ, Bastida S, Librelotto J, Nus M, Corella D et al. Effect of walnut-enriched meat on the relationship between VCAM, ICAM, and LTB4 levels and PON-1 activity in ApoA4 360 and PON-1 allele carriers at increased cardiovascular risk. Eur J Clin Nutr 2011;65:703-10.
6. Chen GC, Lu DB, Pang Z, Liu QF. Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc 2013;2:e000329.
7. Christensen BC, Marsit CJ. Epigenomics in environmental health. Front Genet 2011;2:84.
8. Clifton PM, Keogh J. Metabolic effects of highprotein diets. Curr Atheroscler Rep 2007;9:472-8.
9. Cohen E, Aviram M, Khatib S, Rabin A, Mannheim D, Karmeli R et al. Increased levels of human carotid lesion linoleic acid hydroperoxide in symptomatic and asymptomatic patients is inversely correlated with serum HDL and paraoxonase 1 activity. J Lipids 2012;2012:762560.
10. de la Iglesia R, Lopez-Legarrea P, Celada P, Sanchez-Muniz FJ, Martinez JA, Zulet MA. Beneficial effects of the resmena dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary tac and fruit consumption. Int J Mol Sci 2013;14:6903-19.
11. de la Iglesia R, Lopez-Legarrea P, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L et al. A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. Br J Nutr 2014;111:643-52.
12. Ferretti G, Bacchetti T, Masciangelo S, Grugni G, Bicchiega V. Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome. Dis Model Mech 2012;5:698-705.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C et al. Mzf1 controls cell proliferation and tumorigenesis. Genes Dev 2001; 15:1625-30.
15. Garg PK, Biggs ML, Carnethon M, Ix JH, Criqui MH, Britton KA et al. Metabolic syndrome and risk of incident peripheral artery disease: The cardiovascular health study. Hypertension 2014;63:413-9.
16. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002;22:1329-33.
17. Kheir-Eldin A, Motawi T, Sadik N. Effect of some natural antioxidants on aflatoxin B1-induced hepatic toxicity. EXCLI Journal 2008;7:119-31.
18. Kim DS, Marsillach J, Furlong CE, Jarvik GP. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics 2013;14:1495-515.
19. Koncsos P, Seres I, Harangi M, Pall D, Jozsa L, Bajnok L et al. Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity. J Am Coll Nutr 2011;30:333-9.
20. Kota SK, Meher LK, Jammula S, Krishna SV, Modi KD. Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia. Indian J Endocrinol Metab 2013;17:402-12.
21. Kotani K, Sakane N, Sano Y, Tsuzaki K, Matsuoka Y, Egawa K et al. Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women. J Clin Biochem Nutr 2009;45:329-34.
22. Kumar D, Rizvi SI. Plasma paraoxonase 1 arylesterase activity in D-galactose-induced aged rat model: correlation with LDL oxidation and redox status. Aging Clin Exp Res 2013. doi: 10.1007/s40520-013-0170-2.
23. Lopez-Legarrea P, de la Iglesia R, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutr Metab (Lond) 2013;10:22.
24. Malireddy S, Kotha SR, Secor JD, Gurney TO, Abbott JL, Maulik G et al. Phytochemical antioxidants modulate mammalian cellular epigenome: implications in health and disease. Antioxid Redox Signal 2012;17:327-39.
25. Mansego ML, Milagro FI, Campion J, Martinez JA. Techniques of DNA methylation analysis with nutritional applications. J Nutrigenet Nutrigenomics 2013;6:83-96.
26. Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, Marado D, Palavra F, Pinto R et al. Implication of low HDL-c levels in patients with average LDL-c levels: a focus on oxidized LDL, large HDL subpopulation, and adiponectin. Mediators Inflamm 2013;2013:612038.
27. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008; 372:224-33.
28. Milagro FI, Campion J, Garcia-Diaz DF, Goyenechea E, Paternain L, Martinez JA. High fat dietinduced obesity modifies the methylation pattern of leptin promoter in rats. J Physiol Biochem 2009;65: 1-9.
29. Milagro FI, Campion J, Cordero P, Goyenechea E, Gomez-Uriz AM, Abete I et al. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J 2011;25:1378-89.
30. Mustacich DJ, Bruno RS, Traber MG. Vitamin E. Vitam Horm 2007;76:1-21.
31. Nus M, Sanchez-Muniz FJ, Sanchez-Montero JM. A new method for the determination of arylesterase activity in human serum using simulated body fluid. Atherosclerosis 2006;188:155-9.
32. Nus M, Sanchez-Muniz FJ, Sanchez-Montero JM. Arylesterase. Methodological and functional aspects of a key enzyme in the cardiovascular disease. An Real Acad Farm 2008;74:5-27.
33. Perez-Cornago A, Lopez-Legarrea P, de la Iglesia R, Lahortiga F, Martinez JA, Zulet MA. Longitudinal relationship of diet and oxidative stress with depressive symptoms in patients with metabolic syndrome after following a weight loss treatment: The RESMENA project. Clin Nutr 2013. pii: S0261-5614(13)00317-8. doi: 10.1016/j.clnu.2013.11.011.
34. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28:1057-68.
35. Precourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011;214:20-36.
36. Rector RS, Warner SO, Liu Y, Hinton PS, Sun GY, Cox RH et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab 2007;293:E500-6.
37. Shapiro DS, Loiacono LA. Mean arterial pressure: therapeutic goals and pharmacologic support. Crit Care Clin 2010;26:285-93.
38. Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 2010;1:189-210.
39. Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010;59:71-9.
40. Tabur S, Torun AN, Sabuncu T, Turan MN, Celik H, Ocak AR et al. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation. Eur J Endocrinol 2010;162:535-41.
41. Tsakiris S, Karikas GA, Parthimos T, Tsakiris T, Bakogiannis C, Schulpis KH. Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals. Eur J Clin Nutr 2009;63:215-21.
42. Usta M, Turan E, Aral H, Inal BB, Gurel MS, Guvenen G. Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome. J Clin Lab Anal 2011;25:289-95.
43. Vanderkraats ND, Hiken JF, Decker KF, Edwards JR. Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res 2013;41:6816-27.
44. Vazquez-Velasco M, Esperanza Diaz L, Lucas R, Gomez-Martinez S, Bastida S, Marcos A et al. Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors. Br J Nutr 2011;105: 1448-52.
45. Whitworth JA, Chalmers J. World Health Organization-International Society of Hypertension (WHO/ ISH) hypertension guidelines. Clin Exp Hypertens 2004;26:747-52.
46. Younis NN, Soran H, Charlton-Menys V, Sharma R, Hama S, Pemberton P et al. High-density lipoprotein impedes glycation of low-density lipoprotein. Diab Vasc Dis Res 2013;10:152-60.
47. Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer 2010;1:1178-88.
48. Zulet MA, Bondia-Pons I, Abete I, de la Iglesia R, Lopez-Legarrea P, Forga L et al. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutr Hosp 2011;26:16-26.